DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	IGKV2D-30; IGKV3D-20; IGKV1-12; IGKV2-29; HP; IGKV1D-33; IGKV1-39; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV4-39; IGHV4-59; IGLV7-43; IGKV1-16; IGKV3-11; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; FOLR2; IGHV1-2; FCGR2B; HBA1; IGLV3-21; CLEC9A; FCGR1B;	GO:0006898~receptor-mediated endocytosis	50	160	31.25	0	0	0	0	0	0	0
down	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV3-64; IGHV3-66; IGHV3-72; TRBC2; IGHV1-3; IGHV3-35; IGHV1-18; IGHV3-49; IGHV3-20; IGHV3-21; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGLC2; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	44	99	44.4444444444444	0	0	0	0	0	0	0
down	IGKV2D-30; IGKV3D-20; IGKV1-12; IGKV2-29; FCN1; IGKV1D-33; IGKV1-39; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV4-39; IGHV4-59; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV3-11; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	47	92	51.0869565217391	0	0	0	0	0	0	0
down	HP; ELANE; S100A12; IRF8; CEBPE; TLR9; ADAMTS5; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGLC2; IGHV3-72; IGLL5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV1-58; IGHV4-34; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-35; IGHV3-23; IGHV1-69; IGHV4-31; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33;	GO:0042742~defense response to bacterium	51	216	23.6111111111111	0	0	0	0	0	0	0
down	IGKV2D-30; TRAV19; IGKV3D-20; IGKV1-12; IGKV2-29; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1D-33; IGKV1-39; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-69; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV4-39; IGHV4-59; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; CD8B; CD19; IGHV1-2; KLRC1; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; CLEC4G; TREML4; CD300LD; LILRB2; LILRB1; CD300LF; KIR2DL4; CD300A; COL17A1; SIGLEC7; BTNL8; BTNL3; BTN1A1;	GO:0050776~regulation of immune response	84	216	38.8888888888889	0	0	0	0	0	0	0
down	TLR9; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGLC3; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; TRDC; IGHV3-35; IGHV3-30; IGHV3-43;	GO:0050871~positive regulation of B cell activation	45	98	45.9183673469388	0	0	0	0	0	0	0
down	IGKV2D-30; IGKV3D-20; IGKV1-12; IGKV2-29; IGKV1D-33; IGKV1-39; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV4-39; IGHV4-59; GYPA; IGLV7-43; IGKV1-16; IGKV3-11; GYPB; IGKV5-2; IGHV4-34; CD48; IGLC6; IGLC2; IGLC3; IGHV1-2; CEACAM8; L1CAM; CEACAM3; IGLV3-21; ANGPT1; GP6; SIRPG; CD84;	GO:0050900~leukocyte migration	54	193	27.979274611399	0	0	0	0	0	0	0
down	OR2T8; GPR25; P2RY10; FCN1; GPR171; FFAR3; UTS2; OXT; TSHB; PF4; HRH2; CXCR1; ADRA1D; AVPR2; CXCR5; SSTR3; CNR2; OR1D2; OPRM1; DRD3; AVPR1A; CCR2; CCR10; XCL1; CXCR3; GPR15; CCR5; CCR6; CCR8; OR2B6; NLRP6; TAS2R39; TAS2R40; PTGDR; ADGRE1; OR2B11; PIK3R6; OR2W3; GPR65; OR2L13; OR2L5; OR10G2; OR52L2P; OR56B2P; OR52N4; OR56B1; OR52B4; OR52K2; OR52K1; GPR150; OR6N1; OR2T10; OR2T3; OR52P1P; RXFP4; RXFP2; RLN3; PIK3R5; GHSR; F2RL3; P2RY13; ADGRE3; GPR88; P2RY12; NMUR1; PROK2; CYSLTR2; XCL2; GNG8; GPR55; OR4D1; OR1D5; OR6K3; GNG11; OR6K6; OR5AN1; OR6N2; GPR152; MRGPRD; GNG10; OR5K1;	GO:0007186~G protein-coupled receptor signaling pathway	81	1152	7.03125	0.00011977376555871	0.0140477516462438	0.292607309259946	0.295002784571121	0.292128214197711	0.292607309259946	0.117812228514897
down	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.00017994023789114	0.0198180291806659	0.439414060930166	0.44319280592588	0.43851435974071	0.439414060930166	0.166204972962474
down	TARM1; FCN1; SIGLEC5; TYROBP; FCGR3B; TRPM2; HP; PLAU; ORM1; FTH1; ELANE; RNASE2; FCGR2A; RNASE3; DEFA4; BPI; CD53; ORM2; AZU1; MMP8; FCAR; CXCR1; CEACAM8; CDA; CEACAM3; MNDA; P2RX1; HK3; NCKAP1L; S100A12; RHOG; SIGLEC14; CLEC12A; LILRB2; CLEC4C; RAB24; MS4A3; ADGRE3; RETN; CD300A; TRAPPC1;	GO:0043312~neutrophil degranulation	41	483	8.48861283643892	0.00018983999318722	0.0198180291806659	0.463399423370014	0.467575903220133	0.462450223404078	0.463399423370014	0.166204972962474
up	PRSS38; PRSS37; TRABD2B; CLCA1; ADAMDEC1; KLK10; KLK8; ECEL1; CFB; CFI; MMP3; MMP7; RBP3; CTSE; CPA3; CTRB1; CASP14; GGT5; MMP12; KLK7; RHBDL3; TMPRSS15; WFDC2; HABP2; MMEL1; CPZ; TMPRSS11A; ADAMTSL2; SFRP1; DPP10; ADAMTSL1; ADAMTS15; ADAMTS19; ADAMTS14; GGH; ADAM33; MMP27; TMPRSS4; RHBDL2; KLK12; KLK13; KLK5; CAPN8; PGA5; CAPN9; TPSAB1; CPA6; CPO; TPSB2; CAPN6; PLAT; CAPN14; PGA3; PGC; TPSD1; TPSG1;	GO:0006508~proteolysis	56	436	12.8440366972477	0.00024242897849569	0.0620703749242462	0.772136296508773	0.774803015272226	0.745529791030358	0.772136296508773	0.536724233268422
down	TYROBP; CTLA4; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0002553104089702	0.0251531814917441	0.622702087478317	0.628829537293602	0.591043596766012	0.622702087478317	0.210948516204327
up	ALOX12B; CLDN1; KRT16; FLG; FLG2; FA2H; ABCA12; HRNR; ALOXE3;	GO:0061436~establishment of skin barrier	9	25	36	0.00041492659128916	0.094721813268584	1	1	0.972429892135715	0.999999995245059	0.819062115581266
down	FFAR3; NCR3; IL18RAP; LY86; ORM1; FOLR2; ITGB6; AZU1; CRHBP; CD40LG; FCGR2B; CNR2; MAP2K3; CXCR3; AIF1; NLRP6; S100A12; FUT7; NAIP; NLRP9; IL27; PLD4; CD180; PROK2; TLR9; PF4; PTGDR; PF4V1; CCR5; XCL1; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	33	381	8.66141732283465	0.00055077787624047	0.0502431818214919	1	1	0.881795379860995	0.999999789865398	0.421367160178393
down	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.00058081322659209	0.0510908206105829	1	1	0.900090728408267	0.999999789865398	0.428475928701161
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2E1; CYP2S1; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	8	21	38.0952380952381	0.0006401589860725	0.123301025822929	1	1	0.999999995245059	0.999999995245059	1
up	IVL; KRT10; FLG; SPRR1B; SPRR2E; SPRR1A; TGM3; TGM6; TGM7;	GO:0018149~peptide cross-linking	9	27	33.3333333333333	0.00065585652033473	0.123301025822929	1	1	0.999999995245059	0.999999995245059	1
down	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.00130697969041438	0.103453555399711	1	1	0.999999789865398	0.999999789865398	0.867618834412426
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00143041239102681	0.106760779366638	1	1	0.999999789865398	0.999999789865398	0.895355046978916
up	CCL24; CXCL11; WNT9B; SIGLEC6; CXCL13; CXCL14; CXCL10; THY1; INHA; EDN1; PGR; GJB1; CGB7; BMP2; EDN3; ADCYAP1; NTF3; FGFR3; CCL18; CXCL9; IL17A; FGF14; TBX5; CCL13; BARX1; GJB4; IL36G; CCL26; DRD2; DRD1; ADRA2C; ADRA2A;	GO:0007267~cell-cell signaling	32	230	13.9130434782609	0.00154533242378341	0.259941180337462	1	1	0.999999995245059	0.999999995245059	1
down	LILRA5; ORM1; LPL; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	7	35	20	0.00191169575485106	0.13848548953524	1	1	0.999999789865398	0.999999789865398	1
down	TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00206693706474048	0.145453314013023	1	1	0.999999789865398	0.999999789865398	1
down	OXT; CRHBP; AVPR1A;	GO:0002125~maternal aggressive behavior	3	4	75	0.00242330172752614	0.154474806255614	1	1	0.999999789865398	0.999999789865398	1
down	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00242330172752614	0.154474806255614	1	1	0.999999789865398	0.999999789865398	1
down	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00242330172752614	0.154474806255614	1	1	0.999999789865398	0.999999789865398	1
down	NUAK1; MPDZ; BMP10; GP9; ITGB6; LAMA1; L1CAM; THBS2; GP5; CXCR3; CCR8; CDH11; SRPX; SPOCK1; MYBPH; SLAMF1; LAMC2; COL4A6; ADGRE1; MYBPC3; COL19A1; FEZ1; NTM; SIRPG; CD300A; CLEC4A; NINJ2; SIGLEC5; SIGLEC11; SIGLEC10; SIGLEC14; PCDHGC5; SIGLEC8; SIGLEC7; ICAM3;	GO:0007155~cell adhesion	35	454	7.70925110132159	0.00244600789442506	0.154474806255614	1	1	0.999999789865398	0.999999789865398	1
down	SPI1; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	5	18	27.7777777777778	0.00254861060801559	0.15693069818856	1	1	0.999999789865398	0.999999789865398	1
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.00275588839223229	0.419419966741638	1	1	0.999999995245059	0.999999995245059	1
down	HBA1; HBG2; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.0029628596305542	0.177988372440366	1	1	0.999999789865398	0.999999789865398	1
up	CXCL11; CXCL10; THY1; DRD1; IL13; APLNR; CXCL9; NPSR1;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	8	29	27.5862068965517	0.00349196747950176	0.507287639294892	1	1	0.999999995245059	0.999999995245059	1
down	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00375377375202524	0.215012668633445	1	1	0.999999789865398	0.999999789865398	1
down	SEMG1; ELANE; RNASE3; DEFA4; BPI; AZU1; DEFA3; RNASE6;	GO:0019730~antimicrobial humoral response	8	52	15.3846153846154	0.0039816239492253	0.222334273971263	1	1	0.999999789865398	0.999999789865398	1
down	LAMB3; LAMC2; LAMA3; COL17A1;	GO:0031581~hemidesmosome assembly	4	12	33.3333333333333	0.00406213655245913	0.222334273971263	1	1	0.999999789865398	0.999999789865398	1
down	IGKV3-20; SEMG1; RNASE3; DEFA4; DEFA3; RNASE6;	GO:0019731~antibacterial humoral response	6	31	19.3548387096774	0.00459132395978024	0.245835454629103	1	1	0.999999789865398	0.999999789865398	1
up	SLC26A4; EDN1; EDNRB; ATP12A; ATP6V0A4;	GO:0006885~regulation of pH	5	12	41.6666666666667	0.00504946459307964	0.618640988735438	1	1	0.999999995245059	0.999999995245059	1
up	APOA1; APOC1; APOC3; APOA4; ABCA12;	GO:0033700~phospholipid efflux	5	12	41.6666666666667	0.00504946459307964	0.618640988735438	1	1	0.999999995245059	0.999999995245059	1
up	FGF10; TCF21; HNF1B; FOXF1; OVOL2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	6	18	33.3333333333333	0.00521705404055928	0.618640988735438	1	1	0.999999995245059	0.999999995245059	1
up	PTGES; CXCL13; S100A8; CCL11;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.00527172589120517	0.618640988735438	1	1	0.999999995245059	0.999999995245059	1
down	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00545170867814304	0.268551169485326	1	1	0.999999789865398	0.999999789865398	1
down	APOA2; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00545170867814304	0.268551169485326	1	1	0.999999789865398	0.999999789865398	1
down	CTNNA2; PFN2; WASF3;	GO:0098885~modification of postsynaptic actin cytoskeleton	3	6	50	0.00545170867814304	0.268551169485326	1	1	0.999999789865398	0.999999789865398	1
down	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00545170867814304	0.268551169485326	1	1	0.999999789865398	0.999999789865398	1
up	CYP1A1; CYP2E1; ADH1A; CYP2C9; UGT1A1; CYP2C19; UGT1A7;	GO:0017144~drug metabolic process	7	25	28	0.00576786864399748	0.618640988735438	1	1	0.999999995245059	0.999999995245059	1
up	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00580701804194717	0.618640988735438	1	1	0.999999995245059	0.999999995245059	1
down	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00637829430763848	0.302110363071415	1	1	0.999999789865398	0.999999789865398	1
down	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.00637829430763848	0.302110363071415	1	1	0.999999789865398	0.999999789865398	1
up	CDH16; CEACAM5; DSG4; CADM3; CDHR2; CDHR5; ROBO2; CDH22; PCDHB8; PCDHB10; PCDHGB4; PCDHA7; PCDHA6; PCDHA4; PCDHB5; PCDHGC4; PCDHA9; PCDHA5; CNTN4; CDH19; IGSF21; CDH26; CDH12;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	23	165	13.9393939393939	0.00638836946371069	0.65289158591912	1	1	0.999999995245059	0.999999995245059	1
down	SYT7; CEACAM4; ICAM3; IRF8; SLAMF1; CEBPE; PLD4; ELANE;	GO:0006909~phagocytosis	8	57	14.0350877192982	0.00651021583200762	0.302540784796882	1	1	0.999999789865398	0.999999789865398	1
up	SAA1; CCL26; CCL18; CCL24; CCL14; CCL19; CCL11; CCL13;	GO:0048247~lymphocyte chemotaxis	8	33	24.2424242424242	0.00674137119378315	0.65289158591912	1	1	0.999999995245059	0.999999995245059	1
up	BMPR1B; BMP2; BMP4; DLX5; SFRP1; GATA5; TNMD; TMEM100;	GO:0071773~cellular response to BMP stimulus	8	33	24.2424242424242	0.00674137119378315	0.65289158591912	1	1	0.999999995245059	0.999999995245059	1
down	WNT7A; MTPN; KNDC1;	GO:0021707~cerebellar granule cell differentiation	3	7	42.8571428571429	0.00754120572685579	0.331678387593675	1	1	0.999999789865398	0.999999789865398	1
down	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00754120572685579	0.331678387593675	1	1	0.999999789865398	0.999999789865398	1
down	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.00754120572685579	0.331678387593675	1	1	0.999999789865398	0.999999789865398	1
up	FGF10; BMP2; BMP4; MIF; DRD2; ADCYAP1; FGFR3; FSHR; S100A7; THPO; CASR; P2RY1; P2RY6; SYT14P1; FFAR4; NPNT; CCL19; NOX4; TREM2; CCL11; HMGB1P1; CCL24; CCL14; CCL13; CCL26; NTRK2; CCL18;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	27	209	12.9186602870813	0.00816858488961136	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; DRD2; NPR1; EDNRB; TFAP2B;	GO:0035810~positive regulation of urine volume	5	14	35.7142857142857	0.00844117858620108	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	MT2A; MT1H; MT1L; MT1G;	GO:0010273~detoxification of copper ion	4	16	25	0.00943357647887155	0.361385780791694	1	1	0.999999789865398	0.999999789865398	1
up	CYP2F1; CYP2C19; CYP2E1; CYP2S1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	6	21	28.5714285714286	0.00958581406997261	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	FOXE1; FGF10; GLI2; FGF7; KRT17; TGM3; FOXQ1;	GO:0031069~hair follicle morphogenesis	7	28	25	0.00959593621764065	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CYP2E1; EDN1; SCGB1A1;	GO:0010193~response to ozone	3	4	75	0.00963595493468106	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; EDN3; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.00963595493468106	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	SLC26A4; ANO1; SLC5A5;	GO:0015705~iodide transport	3	4	75	0.00963595493468106	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	MESP1; GATA5; ROBO2;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	3	4	75	0.00963595493468106	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.00963595493468106	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	LILRA5; IFNG; LPL; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	6	37	16.2162162162162	0.00968583754597518	0.361385780791694	1	1	0.999999789865398	0.999999789865398	1
down	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.00969205195184142	0.361385780791694	1	1	0.999999789865398	0.999999789865398	1
down	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0100411349819802	0.361385780791694	1	1	0.999999789865398	0.999999789865398	1
down	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0100411349819802	0.361385780791694	1	1	0.999999789865398	0.999999789865398	1
down	PF4; SEMG1; RNASE3; DEFA4; DEFA3; S100A12; RNASE6; PF4V1;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.0100992423045522	0.361385780791694	1	1	0.999999789865398	0.999999789865398	1
up	EDN1; EDNRA; OCLN; FFAR4;	GO:0010827~regulation of glucose transmembrane transport	4	9	44.4444444444444	0.010204804117385	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	APOA1; APOC3; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	4	9	44.4444444444444	0.010204804117385	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	AKR1B15; AKR1B10; LRAT; CYP1A1; ALDH1A3; BCO1; ADH1C; ADH1A; ADH1B;	GO:0042572~retinol metabolic process	9	44	20.4545454545455	0.0105848511960183	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	MUC6; MUC4; MUC13; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	5	15	33.3333333333333	0.0106175737203816	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	ADCYAP1; ADCYAP1R1; SCTR; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	5	15	33.3333333333333	0.0106175737203816	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	IFNG; AZU1; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.0110891654988265	0.379341869772358	1	1	0.999999789865398	0.999999789865398	1
down	HP; HBZ; HBD; HBG1; HBG2; HBA1; HBM; LOXHD1; CYGB;	GO:0098869~cellular oxidant detoxification	9	77	11.6883116883117	0.0114828712190593	0.387428928938947	1	1	0.999999789865398	0.999999789865398	1
down	GPR65; P2RY10; DRD3; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	6	39	15.3846153846154	0.0120389167597243	0.400700702421636	1	1	0.999999789865398	0.999999789865398	1
down	INHBA; MMP8; HMGA2; LAMB3; LAMA3;	GO:0035987~endodermal cell differentiation	5	28	17.8571428571429	0.0126174604263387	0.40423279196832	1	1	0.999999789865398	0.999999789865398	1
down	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.0129656478138438	0.40423279196832	1	1	0.999999789865398	0.999999789865398	1
down	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0129656478138438	0.40423279196832	1	1	0.999999789865398	0.999999789865398	1
down	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0129656478138438	0.40423279196832	1	1	0.999999789865398	0.999999789865398	1
down	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0129656478138438	0.40423279196832	1	1	0.999999789865398	0.999999789865398	1
up	EDN1; EDN3; EDNRB; EDNRA; HTR1D;	GO:0042310~vasoconstriction	5	16	31.25	0.0131481161894905	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	MT2A; MT1G; MT1H; MT1L;	GO:0045926~negative regulation of growth	4	18	22.2222222222222	0.0133075251119695	0.409705429384762	1	1	0.999999789865398	0.999999789865398	1
down	RNASE2; RNASE3; DEFA4; AZU1; LYPD8; RNASE6; TLR9; BPI; DEFA3;	GO:0050829~defense response to Gram-negative bacterium	9	80	11.25	0.0141753134726887	0.423815436091553	1	1	0.999999789865398	0.999999789865398	1
down	VIL1; AIF1; LMOD2; CATIP; WASF3;	GO:0030041~actin filament polymerization	5	29	17.2413793103448	0.0142820467704421	0.423815436091553	1	1	0.999999789865398	0.999999789865398	1
down	ORM1; BPI; NCKAP1L; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	5	29	17.2413793103448	0.0142820467704421	0.423815436091553	1	1	0.999999789865398	0.999999789865398	1
up	CHP2; BMP2; RGN;	GO:0010922~positive regulation of phosphatase activity	3	5	60	0.0146220928733158	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; EDN3; CPE;	GO:0030072~peptide hormone secretion	3	5	60	0.0146220928733158	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	3	5	60	0.0146220928733158	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CD1A; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	3	5	60	0.0146220928733158	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	DRD2; DRD1; GDNF;	GO:0051584~regulation of dopamine uptake involved in synaptic transmission	3	5	60	0.0146220928733158	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDNRB; P2RY1; VIP;	GO:0060406~positive regulation of penile erection	3	5	60	0.0146220928733158	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.0146220928733158	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	GRID2; CEACAM5; SELE; LGALS7; CXADR; REG3A; CADM3; CD209; IGSF21;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	9	47	19.1489361702128	0.0150097987630617	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	KRT6A; KRT16; SERPINB5; CA9; TBX5;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.0160558147020367	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CLDN3; CLDN1; ADRA2A; REG3A; OCLN; DUOX2;	GO:0090303~positive regulation of wound healing	6	24	25	0.0160799494612039	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	AVPR2; AVPR1A; SPX;	GO:0003084~positive regulation of systemic arterial blood pressure	3	10	30	0.0163246486106778	0.428358712379905	1	1	0.999999789865398	0.999999789865398	1
down	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0163246486106778	0.428358712379905	1	1	0.999999789865398	0.999999789865398	1
down	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0163246486106778	0.428358712379905	1	1	0.999999789865398	0.999999789865398	1
down	TAL1; SOX8; NR2E1; WNT1; GATA1; WNT7A; WNT8B;	GO:0045165~cell fate commitment	7	55	12.7272727272727	0.016645399671983	0.428358712379905	1	1	0.999999789865398	0.999999789865398	1
up	CYP2C9; CYP2C19; CYP2F1; CYP2C18; CYP2S1; CYP2E1;	GO:0042738~exogenous drug catabolic process	6	25	24	0.0187894225052965	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	PTGES; HPGDS; GSTA1; CYP4F8; CYP2S1;	GO:0006693~prostaglandin metabolic process	5	18	27.7777777777778	0.0193615221801881	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	DES; KRT9; KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	5	18	27.7777777777778	0.0193615221801881	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	ELANE; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0201242303906832	0.500666459113665	1	1	0.999999789865398	0.999999789865398	1
down	ELANE; TGFB2; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.0201242303906832	0.500666459113665	1	1	0.999999789865398	0.999999789865398	1
down	OXT; CPS1; OPRM1; GHSR;	GO:0032094~response to food	4	21	19.047619047619	0.020792964241599	0.507060108188698	1	1	0.999999789865398	0.999999789865398	1
down	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.020792964241599	0.507060108188698	1	1	0.999999789865398	0.999999789865398	1
up	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.0208059659860917	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	HRH1; P2RY1; P2RY6;	GO:0032962~positive regulation of inositol trisphosphate biosynthetic process	3	6	50	0.0208059659860917	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CXCL13; CYP7B1; CH25H;	GO:0035754~B cell chemotaxis	3	6	50	0.0208059659860917	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CYP2E1; UGT1A1; CYP2C19;	GO:0046483~heterocycle metabolic process	3	6	50	0.0208059659860917	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	TCF21; FOXF1; STRA6;	GO:0060426~lung vasculature development	3	6	50	0.0208059659860917	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; EDN3; HRH1; GPR62;	GO:0048016~inositol phosphate-mediated signaling	4	12	33.3333333333333	0.0219625097977629	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	5	33	15.1515151515152	0.0223952892640984	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	IGF1; S100A11; POSTN; P2RY6; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	5	19	26.3157894736842	0.0230837506379985	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.0243670767096817	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0243670767096817	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	TERT; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.0243670767096817	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	SPTA1; HLA-DMB; CD40LG; AIF1; NCKAP1L; CLECL1; LILRB2;	GO:0042102~positive regulation of T cell proliferation	7	61	11.4754098360656	0.0263556749433433	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	DEFB104A; CCL26; CCL14; CCL18; CCL19; CCL13; CCL11; CCL24;	GO:0002548~monocyte chemotaxis	8	44	18.1818181818182	0.0269892028913812	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	HOXB1; HOXB6; HOXD10; HOXD3; HOXA6; HOXD9; HOXD4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	8	44	18.1818181818182	0.0269892028913812	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	FGF10; MDK; FGF7; REG3A;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.0271665237068591	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CYP1A1; HNF1B; HNF4A; PCK1;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.0271665237068591	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EPCAM; HNF4A; P2RY1; MESP1; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	5	20	25	0.0272385316732853	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CCL24; HRH1; CCL11; CCL13; CCL18;	GO:0048245~eosinophil chemotaxis	5	20	25	0.0272385316732853	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	CD300LD; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0273803563868682	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	XCL1; NCKAP1L; TGFB2; S100A12; XCL2; CXCR1; PF4; PF4V1;	GO:0030593~neutrophil chemotaxis	8	76	10.5263157894737	0.0277306147346845	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	CYP1A1; CYP2E1; CYP4A22;	GO:0002933~lipid hydroxylation	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	BMP4; GDNF; SIX2;	GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	AQP1; SCTR; AQP4;	GO:0009992~cellular water homeostasis	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CDHR2; CDHR5; USH1C;	GO:0032532~regulation of microvillus length	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	BMP2; BMP4; DMRT3;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; EDN3; P2RY1;	GO:0046887~positive regulation of hormone secretion	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CYP7B1; ID4; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; EDNRB; EDNRA;	GO:0086100~endothelin receptor signaling pathway	3	7	42.8571428571429	0.0282013730356736	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	WNT1; INHBA; CCR2; TGFB2; HHEX; F2RL3; LYVE1;	GO:0009611~response to wounding	7	62	11.2903225806452	0.0282829559265328	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	ADRA2A; DRD1; DRD2; PMCHL2; ADRA2C; PMCH;	GO:0007610~behavior	6	28	21.4285714285714	0.0287389407158632	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0290528321305665	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	WNT1; AR; GHSR;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.0290528321305665	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	CCR2; SLC46A2; TBX21;	GO:0045580~regulation of T cell differentiation	3	13	23.0769230769231	0.0290528321305665	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	LPL; VIL1; MS4A1; GZMA; FCGR2B; CD79B; IL27; REG4; NLRP6;	GO:0009617~response to bacterium	9	92	9.78260869565217	0.0296997421470079	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	CDH16; CDH22; PCDHB10; PCDHGB4; PCDHB5; CDH26; CDH12; CDH19;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	8	45	17.7777777777778	0.0299055320815587	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	PF4; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0304248120990663	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	PF4; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.0304248120990663	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	LILRA5; IFNG; LPL; OSM; CCR2; S100A12; TLR9; TLR7;	GO:0050729~positive regulation of inflammatory response	8	78	10.2564102564103	0.0313506298943662	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	GLI2; BMP2; BMP4; FGFR3; HES5; AMELX; SIX2;	GO:0002062~chondrocyte differentiation	7	37	18.9189189189189	0.0317333757117252	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CLDN1; CXADR; OCLN; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	5	21	23.8095238095238	0.031839319690629	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	BMP2; BMP4; TBX5; MESP1; NOX4;	GO:0055007~cardiac muscle cell differentiation	5	21	23.8095238095238	0.031839319690629	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CTAGE4; CTAGE8; CTAGE3P; CTAGE6;	GO:0035459~vesicle cargo loading	4	14	28.5714285714286	0.0330443878026209	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; DRD2; NPR1; EDNRB;	GO:0035815~positive regulation of renal sodium excretion	4	14	28.5714285714286	0.0330443878026209	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	GCNT3; FABP1; ADRA2A; MOGAT2;	GO:0050892~intestinal absorption	4	14	28.5714285714286	0.0330443878026209	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	CD40LG; XCL1; TIGIT; TLR9;	GO:0032733~positive regulation of interleukin-10 production	4	25	16	0.0341296406690591	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	MT2A; MT1G; MT1H; MT1L;	GO:0071294~cellular response to zinc ion	4	25	16	0.0341296406690591	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	OXT; DRD3; AVPR1A;	GO:0035815~positive regulation of renal sodium excretion	3	14	21.4285714285714	0.0341784433813048	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	HBZ; EPB42; TAL1;	GO:0043249~erythrocyte maturation	3	14	21.4285714285714	0.0341784433813048	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	UPK3A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.0341784433813048	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	CLDN3; CLDN1; OCLN; MARVELD2; POF1B; MARVELD3; CRB3;	GO:0070830~bicellular tight junction assembly	7	38	18.4210526315789	0.0353909768673346	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	TRABD2B; NOTUM; SFRP1; FRZB; BARX1; DKK4; WIF1; NKD2;	GO:0030178~negative regulation of Wnt signaling pathway	8	47	17.0212765957447	0.0363714227547052	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	SULT1C2; INMT; CYP1A1;	GO:0009308~amine metabolic process	3	8	37.5	0.0367999907148402	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	ADRA2A; ADRA2C; P2RY1;	GO:0010700~negative regulation of norepinephrine secretion	3	8	37.5	0.0367999907148402	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	PRKD1; OVOL2; EPB41L4B;	GO:0010837~regulation of keratinocyte proliferation	3	8	37.5	0.0367999907148402	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	APOA4; AADAC; APOA1;	GO:0010898~positive regulation of triglyceride catabolic process	3	8	37.5	0.0367999907148402	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	HOXD9; HOXD10; TFAP2B;	GO:0035137~hindlimb morphogenesis	3	8	37.5	0.0367999907148402	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.0367999907148402	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	AQP1; SCNN1G; AQP4;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.0367999907148402	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	FGF10; GLI2; BMP4; HNF1B; CASR;	GO:0048754~branching morphogenesis of an epithelial tube	5	22	22.7272727272727	0.0368969346043229	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	PGR; EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	4	15	26.6666666666667	0.0396052435936626	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CIDEA; APOC1; APOC3; ADRA2A;	GO:0050995~negative regulation of lipid catabolic process	4	15	26.6666666666667	0.0396052435936626	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	XCL1; HOMER3; TBX21;	GO:0032703~negative regulation of interleukin-2 production	3	15	20	0.0397384731960444	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	NCKAP1L; TGFB2; P2RY12;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.0397384731960444	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	NLRP6; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.0397384731960444	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.0397384731960444	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	CRHBP; OPRM1; DRD3;	GO:0048149~behavioral response to ethanol	3	15	20	0.0397384731960444	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	IFNG; FCER2; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.0397384731960444	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	FLRT2; CTNNA2; SCRT2;	GO:2001222~regulation of neuron migration	3	15	20	0.0397384731960444	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	CD3G; ACTB; CRB1; CAP2; RHOG; PARVG;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.040348917175437	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	SPTA1; TAL1; FLT3; CCR2; TGFB2; ANGPT1;	GO:0030097~hemopoiesis	6	53	11.3207547169811	0.040348917175437	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	MMP8; SCIMP; LILRB2; TLR9; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.040348917175437	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	SELE; EDNRA; NTF4; ADCYAP1R1; P2RY6; NTRK2;	GO:0007202~activation of phospholipase C activity	6	31	19.3548387096774	0.0416404704565583	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	RCVRN; CABP4; TRPC3; GPR88;	GO:0007602~phototransduction	4	27	14.8148148148148	0.0422911963910565	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	FFAR3; OXT; DRD3; VEGFC;	GO:0045776~negative regulation of blood pressure	4	27	14.8148148148148	0.0422911963910565	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0457253887100818	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.0457253887100818	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	UPK3A; SLC12A3; SLC12A1;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.0457253887100818	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	BMP4; FOXF1; TBX5;	GO:0003197~endocardial cushion development	3	9	33.3333333333333	0.0465753979314083	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	CYP4F8; PTGIS; CYP2S1;	GO:0006690~icosanoid metabolic process	3	9	33.3333333333333	0.0465753979314083	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	VIP; EDN1; NPR1;	GO:0007589~body fluid secretion	3	9	33.3333333333333	0.0465753979314083	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	APOA1; APOC1; APOA4;	GO:0010873~positive regulation of cholesterol esterification	3	9	33.3333333333333	0.0465753979314083	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	FGF10; CLDN1; MMP12;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	3	9	33.3333333333333	0.0465753979314083	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	SCNN1G; CLCNKB; AMN; UGT1A7; ATP6V0A4; CLDN16;	GO:0007588~excretion	6	32	18.75	0.0466338869313216	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	IGF1; FGF1; ADRA2A; ADRA2C; NTF3; DYNAP;	GO:0032148~activation of protein kinase B activity	6	32	18.75	0.0466338869313216	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
down	NCKAP1L; GPR174; SLC46A2; SIT1;	GO:0043029~T cell homeostasis	4	28	14.2857142857143	0.0467486293756819	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
down	DEFA4; DEFA3; S100A12; CLEC6A;	GO:0050832~defense response to fungus	4	28	14.2857142857143	0.0467486293756819	0.519837845103511	1	1	0.999999789865398	0.999999789865398	1
up	PTGES; EDN1; MIF; PTGIS;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.046852161061949	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	EDN1; ADRA2A; EDN3; ACE2;	GO:0019229~regulation of vasoconstriction	4	16	25	0.046852161061949	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	GLI2; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	4	16	25	0.046852161061949	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	BMP5; FOXA1; SFRP1; TBX5; OVOL2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.0484126569353969	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
up	FGF10; HNF1B; NKX6-1; FOXF1; MSLN;	GO:0031016~pancreas development	5	24	20.8333333333333	0.0484126569353969	0.706444301152954	1	1	0.999999995245059	0.999999995245059	1
